This timely online event examines why diversifying regional supply chains—particularly through intentional, well-structured CDMO partnerships—must happen now. Industry experts will explore how geographic concentration magnifies risk, how regional CDMO collaboration strengthens supply continuity and compliance, and how diversification enables faster, more flexible, and more scalable manufacturing responses.

Editorial Panel: Outsourced Pharma's Perry Rearick with Top CDMO Executives on What They Are Seeing. Successful customer strategies, urgently needed action and partnership imperatives. With Thermo's Commercial President Jennifer Cannon, Top Industry KOL John Chiminski, and Novartis' Christoph Buerki, Global Head of Procurement and CDMO.

Special Fireside Chat: Partnering and Co-Investing with CDMOs for Customized Regional Capacity, Enzene's VP, Global Marketing and Sales Russell Miller and Wilmington PharmaTech's Managing Partner Kent Payne join Orientation Marketing's Board of Directors and Strategic Advisor Elliott Berger to speak about creating custom partnerships for bespoke capacity between pharma manufacturers and CDMOs - different models, investment options, capability matching, technology licensing and more. They will discuss various partnering options and specifically how EnzeneX technology enables faster, more efficient build-out of continuous biomanufacturing capacity. They’ll also learn how Wilmington's 54-acre campus permitted a full range of chemical capacity in a co-investment approach leading to faster build-outs for API production.

Exclusive Interview: "The CDMO Man in Washington on the Latest Developments" -Elliott Berger, Board of Directors and Strategic Advisor at Orientation Marketing chats with Gil Roth, Pharma & Biopharma Outsourcing Association President.

Rapid Fire: On-Shoring Readiness Presentation from Top US and European CDMOs.

Register for the event here.